Abstract

IntroductionMicroRNAs (miRNAs) are small, non-coding RNA molecules that have powerful regulatory properties, with the ability to regulate multiple messenger RNAs (mRNAs) and biological pathways. MicroRNA-223-3p (miR-223) is known to be a critical regulator of the innate immune response, and its dysregulation is thought to play a role in inflammatory disease progression. Despite miR-223 upregulation in numerous neurodegenerative conditions, largely in cells of the myeloid lineage, the role of miR-223 in the retina is relatively unexplored. Here, we investigated miR-223 in the healthy retina and in response to retinal degeneration.MethodsmiR-223-null mice were investigated in control and photo-oxidative damage-induced degeneration conditions. Encapsulated miR-223 mimics were intravitreally and intravenously injected into C57BL/6J wild-type mice. Retinal functional responses were measured using electroretinography (ERG), while extracted retinas were investigated by retinal histology (TUNEL and immunohistochemistry) and molecular analysis (qPCR and FACS).ResultsRetinal function in miR-223–/– mice was adversely affected, indicating that miR-223 may be critical in regulating the retinal response. In degeneration, miR-223 was elevated in the retina, circulating serum, and retinal extracellular vesicles. Conversely, retinal microglia and macrophages displayed a downregulation of miR-223. Further, isolated CD11b+ inflammatory cells from the retinas and circulation of miR-223-null mice showed an upregulation of pro-inflammatory genes that are critically linked to retinal inflammation and progressive photoreceptor loss. Finally, both local and systemic delivery of miR-223 mimics improved retinal function in mice undergoing retinal degeneration.ConclusionmiR-223 is required for maintaining normal retinal function, as well as regulating inflammation in microglia and macrophages. Further investigations are required to determine the targets of miR-223 and their key biological pathways and interactions that are relevant to retinal diseases. Future studies should investigate whether sustained delivery of miR-223 into the retina is sufficient to target these pathways and protect the retina from progressive degeneration.

Highlights

  • MicroRNAs are small, non-coding RNA molecules that have powerful regulatory properties, with the ability to regulate multiple messenger RNAs and biological pathways

  • Genes for pro-inflammatory panels were selected on the following basis: (1) C-C motif ligand 3 (Ccl3), NLR family pyrin domain containing 3 (Nlrp3), and signal transducer and activator of transcription 3 (Stat3) are validated targets of miR-223-3p (Bauernfeind et al, 2012; Chen et al, 2012; Dorhoi et al, 2013) and are known to be involved in retinal degenerative diseases (Doyle et al, 2012; Kohno et al, 2014; Chen et al, 2016, 2019; Fernando et al, 2016; Wooff et al, 2020b); (2) we have shown that component 1qa (C1qa), component 3 (C3), and Il-1β are all critically linked to retinal disease progression in photo-oxidative damage (Natoli et al, 2017a,b; Jiao et al, 2018); and (3) cathepsin E (Ctse) is a predicted target of miR-223-3p and is involved in key inflammatory cell functions (Gantier, 2013)

  • We investigated reactive gliosis by staining for the marker GFAP, which showed no significant change in the intensity or area of GFAP staining between miR-223−/− and WT groups (Figures 1D–F, P > 0.05)

Read more

Summary

Introduction

MicroRNAs (miRNAs) are small, non-coding RNA molecules that have powerful regulatory properties, with the ability to regulate multiple messenger RNAs (mRNAs) and biological pathways. MicroRNA-223-3p (miR-223) is known to be a critical regulator of the innate immune response, and its dysregulation is thought to play a role in inflammatory disease progression. By binding to the 3 untranslated region (3 UTR) of a messenger RNA (mRNA), the mRNA is targeted for translational repression or degradation (reviewed in Bartel, 2004). Within the retina, miRNAs are known to play a major role in the development and disease of the photoreceptors, bipolar cells, and Müller cells (Zuzic et al, 2019), including the regulation of retinal inflammation (Anasagasti et al, 2018; Chu-Tan et al, 2018)

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call